Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
Turkey · Delayed Price · Currency is TRY 25.28
+0.16 (0.64%)
Last updated: Aug 17, 2026, 10:14 AM GMT+3
IST:MEDTR Ratios and Metrics
Market cap in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,989 | 3,422 | 6,295 | 3,313 | 4,762 | 1,754 | |
Market Cap Growth | -31.81% | -45.63% | 90.01% | -30.44% | 171.45% | - |
Enterprise Value | 2,568 | 3,051 | 5,954 | 3,000 | 4,482 | 1,536 |
Last Close Price | 25.12 | 28.63 | 52.24 | 27.32 | 37.52 | 12.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 109.26 | - | 65.50 | 88.71 | 41.65 | 10.46 |
PS Ratio | 1.09 | 1.19 | 2.30 | 1.58 | 2.98 | 4.67 |
PB Ratio | 0.94 | 1.17 | 2.15 | 1.55 | 3.16 | 3.08 |
P/TBV Ratio | 0.98 | 1.21 | 2.17 | 1.56 | 3.17 | 3.09 |
P/FCF Ratio | 7.22 | 13.65 | 11.78 | 6.61 | - | 63.28 |
P/OCF Ratio | 4.85 | 7.86 | 8.06 | 4.14 | 100.98 | 47.88 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.94 | 1.06 | 2.17 | 1.43 | 2.81 | 4.09 |
EV/EBITDA Ratio | 10.66 | 11.16 | 14.24 | 6.69 | 10.38 | 15.34 |
EV/EBIT Ratio | 39.53 | 28.72 | 19.56 | 7.93 | 11.62 | 17.25 |
EV/FCF Ratio | 6.21 | 12.17 | 11.14 | 5.98 | - | 55.42 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.06 | 0.06 | 0.06 |
Debt / EBITDA Ratio | 0.12 | 0.14 | 0.15 | 0.27 | 0.19 | 0.31 |
Debt / FCF Ratio | 0.08 | 0.16 | 0.12 | 0.25 | - | 1.12 |
Net Debt / Equity Ratio | -0.14 | -0.12 | -0.17 | -0.23 | -0.34 | -0.64 |
Net Debt / EBITDA Ratio | -1.78 | -1.27 | -1.21 | -1.09 | -1.19 | -3.63 |
Net Debt / FCF Ratio | -1.08 | -1.39 | -0.95 | -0.97 | 11.79 | -13.11 |
Asset Turnover | 0.80 | 0.79 | 0.86 | 0.91 | 1.22 | 0.71 |
Inventory Turnover | 3.37 | 3.29 | 3.13 | 3.56 | 5.43 | 3.73 |
Quick Ratio | 2.28 | 2.19 | 1.95 | 2.61 | 3.64 | 4.19 |
Current Ratio | 3.58 | 3.36 | 3.38 | 3.80 | 5.03 | 4.87 |
Return on Equity (ROE) | 1.03% | -0.40% | 3.64% | 2.05% | 11.00% | 42.64% |
Return on Assets (ROA) | 1.56% | 1.83% | 5.93% | 10.24% | 18.49% | 10.50% |
Return on Invested Capital (ROIC) | 3.22% | 4.25% | 14.50% | 13.36% | 37.52% | 35.89% |
Return on Capital Employed (ROCE) | 2.60% | 3.50% | 9.90% | 16.30% | 23.40% | 15.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.92% | -0.27% | 1.53% | 1.13% | 2.40% | 9.56% |
FCF Yield | 13.84% | 7.33% | 8.49% | 15.14% | -0.92% | 1.58% |
Dividend Yield | 1.00% | - | 0.48% | 1.08% | - | - |
Payout Ratio | 138.03% | - | 47.14% | 401.66% | 122.45% | - |
Buyback Yield / Dilution | - | - | - | - | - | -25.93% |
Total Shareholder Return | 1.00% | - | 0.48% | 1.08% | - | -25.93% |